We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANSM Orders Halt of Vaccine Production At Theravectys Over GMP Lapses
ANSM Orders Halt of Vaccine Production At Theravectys Over GMP Lapses
France’s National Agency for Medicines and Health Products Safety has ordered vaccine maker Theravectys to halt production at its Villejuif plant for seven months after finding numerous GMP deficiencies.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor